To investigate if adjuvant sequential RT plus chemotherapy can improve locoregional recurrence-free survival (LRFS) compared with adjuvant chemotherapy alone.
This guideline covers assessing and managing oesophago-gastric cancer in adults, including radical and palliative treatment and nutritional support.
Background & aims: Based on results from year 2 of a 5-year trial, in 2012 the US Food and Drug Administration approved the use of a magnetic device to augment lower esophageal sphincter function in patients with gastroesophageal reflux disease (GERD).
A new post-hoc analysis demonstrates that the decline in health-related quality of life (HRQL) scores associated with a heart failure...
A newly-published clinical study evaluating 217 patients with gastroesophageal reflux disease (GERD) for ten years after receiving Stretta RF Therapy,...
Unmet needs in urothelial cancer management represent an important challenge in our effort to improve long-term overall and disease-free survival rates with no significant compromise in quality of life.
Medtronic plc announced the first patient enrolled in the Expand URO U.S. clinical trial for the Hugo robotic-assisted surgery (RAS) system
This guideline covers rehabilitation strategies for adults who have experienced a critical illness and stayed in critical care.
Background: Chronic rhinosinusitis with nasal polyposis (CRSwNP) negatively affects healthârelated quality of life (HRQoL). In a previously reported randomized clinical trial (NCT01920893), addition of dupilumab to mometasone furoate in patients with CRSwNP refractory to intranasal corticosteroids (INCS) significantly improved endoscopic, radiographic, and clinical endpoints and patientâreported outcomes.